Association of an activated clotting time < or =250 seconds with adverse event rates after percutaneous coronary intervention using tirofiban and heparin (a TACTICS-TIMI 18 substudy).

Source:http://linkedlifedata.com/resource/pubmed/id/12686341

Am. J. Cardiol. 2003 Apr 15 91 8 976-8, A4

Download in:

View as

General Info

PMID
12686341